CLINICAL ROLE -
New Imaging Technique Quadruples Breast Cancer Detection Rates
Technology locates tumors otherwise obscured by dense breast tissue on a mammogram.
Read More
Smoking Increases Side Effect Risks for Prostate Cancer Patients
Smokers have greater risk for recurrence of cancer.
Pharmaceutical Shipping Takes to the Ground
Cost and cold chain concerns drive a decrease in shipping via air freight.
FDA Approves First Drug for Rare Form of Non-Hodgkin Lymphoma
Breakthrough therapy becomes first treatment approved for cancer that attacks immune system.
Long Term Hormonal Contraceptive Use Linked to Rare Brain Cancer
Use of a hormonal contraceptive for at least 5 years linked to potential increase in development of glioma of the brain.
Anti-Epilepsy Drug May Reduce Cancer Spread
Repurposing drugs that block sodium channels may offer a novel therapy for cancer.
The FDA today approved the expanded use of a breakthrough therapy for the treatment of a rare form of cancer that attacks the immune system.
Researchers Propose New Off-Label Drug Regulations
System would provide more treatment options for patients along with evidence of drug safety and efficacy for regulators.
Doctors Perform First Successful Organ Donation from Newborn in UK
Kidneys transplanted from infant who died days after birth.
Breast Cancer Prevention Drug Risks Outweigh Benefits for Most Women
Benefits of tamoxifen varies among patients.
Multiple Sclerosis Cognitive Fatigue Affected by Task Length
Researchers gain insight into the cause of fatigue in MS patients.
Melanoma Becomes Resistant to New Combination Therapy Through Genetic Changes
Researchers discover how cancer resists BRAF+MEK inhibitors.
Patients in Southern United States Have Lower HIV Survival Rate
Nine state region found to have lowest survival rates nationwide.
Breast Cancer Drug Active and Well Tolerated in First Line Setting
Eribulin evaluated for the first time as an early metastatic breast cancer treatment.
Clinical Trials Set for Cancer Fighting Therapy With Broad Applications
Chimeric antigen receptor may be able to treat a number of cancer types.
Hepatitis C Drug Will No Longer Be Sold in United States
Popularity of new treatments lead to shrinking demand for Merck's Victrelis.
Targeted Treatment Inhibits Growth of Aggressive Cancers
Pathway discovered that allows aggressive tumors to proliferate.
Coffee Has Protective Effect Against Non-Melanoma Skin Cancers
Protective effect less clear for cutaneous melanoma.
Stem Cell Transplant May Reduce Disability in Multiple Sclerosis Patients
Stem cell transplantation associated with improvements in disability measures and quality of life.
Panels Split on Restricted Access to Compounded Medications for US Military Families
High level of need cited among 9.5 million active and retired servicemen and their families.
Heart Attack Risk Declines in HIV-Positive Patients
Decrease attributed to less toxic therapies and risk reduction measures.
Protein Limits Fibrosis in Inflammatory Bowel Disease
Process may reduce bowel obstructions and surgeries.
Increased Hepatitis C Screening May Cause More Harm Than Good
Study warns there is no testing to support a net clinical benefit.
Children of Melanoma Survivors Not Protecting Themselves from UV Rays
Study finds lack of adherence to sun protection recommendations.
Protein Interaction May Provide Target for Brain Cancer Therapies
Discovery may provide hope for treatment of most common form of brain cancer.
Rate of Investment in Medical Research Decreases in US, Increases Globally
United States devoting less resources to pharmaceutical industry.
Solving the Hepatitis C Drug Adherence Dilemma
Walgreens official discusses programs and techniques for improving patient adherence.
Preoperative Radiation Therapy Shows Favorable Rectal Cancer Overall Survival Rate
Chemoradiotherapy regimen before surgery found to be effective in patients with localized rectal cancer.
Six Week Hepatitis C Drug Regimen Shows High Cure Rates
Thirty-eight of 40 hepatitis C patients treated with 3-drug combination cured in a recent trial.
Drug Extends Survival for Patients With Rare Cancer
Sunitinib found to provide unprecedented antitumor activity in treatment of thymic carcinoma.